Min-Lan Tsai

Dr. Min-Lan Tsai

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Pediatrics & Neonatology
Verified
Journal Article
Closed access
MTMin-Lan Tsai
Min-Lan Tsai
KHKun-Long Hung
Kun-Long Hung
HLHui-Hua Lu
Hui-Hua Lu

1 June 2015 in Epilepsy & Behavior
Verified
Journal Article
Closed access
PDF file
MTMin-Lan Tsai
Min-Lan Tsai
KHKun-Long Hung
Kun-Long Hung
YTYing-Ying Tsan
Ying-Ying Tsan
WTWilliam Tao-Hsin Tung
William Tao-Hsin Tung

1 May 2012 in Journal of the Formosan Medical Association
Verified
Journal Article
Closed access
MTMin-Lan Tsai
Min-Lan Tsai
KHKun-Long Hung
Kun-Long Hung
WTWilliam Tao-Hsin Tung
William Tao-Hsin Tung
TCTsuey-Ru Chiang
Tsuey-Ru Chiang

1 November 2018 in Epilepsy Research
Verified
Journal Article
Closed access
MTMin-Lan Tsai
Min-Lan Tsai
CCChi-Long Chen
Chi-Long Chen
KHKevin Li-Chun Hsieh
Kevin Li-Chun Hsieh
JMJames S. Miser
James S. Miser
HCHsi Chang
Hsi Chang
TWTai-Tong Wong
Tai-Tong Wong

22 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
HTHuy Tran
Huy Tran
KWKuo-Sheng Wu
Kuo-Sheng Wu
SSShian-Ying Sung
Shian-Ying Sung
CCChun Austin Changou
Chun Austin Changou
THTsung-Han Hsieh
Tsung-Han Hsieh
TWTai-Tong Wong
Tai-Tong Wong
Atypical teratoid rhabdoid tumors (ATRTs) are among the most malignant brain tumors in early childhood and remain incurable. Myc-ATRT is driven by the Myc oncogene, which directly controls the intracellular protein synthesis rate. Proteasome inhibitor bortezomib (BTZ) was approved by the Food and Drug Administration as a primary treatment for multiple myeloma. This study aimed to determine whether the upregulation of protein synthesis and proteasome degradation in Myc-ATRTs increases tumor cell sensitivity to BTZ. We performed differential gene expression and gene set enrichment analysis on matched primary and recurrent patient-derived xenograft (PDX) samples from an infant with ATRT. Concomitant upregulation of the Myc pathway, protein synthesis and proteasome degradation were identified in recurrent ATRTs. Additionally, we found the proteasome-encoding genes were highly expressed in ATRTs compared with in normal brain tissues, correlated with the malignancy of tumor cells and were essential for tumor cell survival. BTZ inhibited proliferation and induced apoptosis through the accumulation of p53 in three human Myc-ATRT cell lines (PDX-derived tumor cell line Re1-P6, BT-12 and CHLA-266). Furthermore, BTZ inhibited tumor growth and prolonged survival in Myc-ATRT orthotopic xenograft mice. Our findings suggest that BTZ may be a promising targeted therapy for Myc-ATRTs.

1 July 2021 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
SPSyu-Jyun Peng
Syu-Jyun Peng
TWTai-Tong Wong
Tai-Tong Wong
CHChao-Ching Huang
Chao-Ching Huang
HCHsi Chang
Hsi Chang
KHKevin Li-Chun Hsieh
Kevin Li-Chun Hsieh
CCChi-Long Chen
Chi-Long Chen
Epileptic surgery is the potentially curative treatment for children with refractory seizures. The study aimed to quantify and analyze high frequency oscillation (HFO) ripples and interictal epileptiform discharges (EDs) in intraoperative electrocorticography (ECoG) between malformation of cortical dysplasia (MCD) and non-MCD children with MRI-lesional focal epilepsy, and evaluate of seizure outcomes after epileptic surgery. The intraoperative ECoG was performed before and after lesionectomy. Quantifications of HFO ripples and interictal EDs of ECoG by frequency, amplitude, and foci of intraoperative ECoG were performed based on electrode location, and the characteristics of ECoG recordings were analyzed in each patient based on their histopathology. Seizure outcome after surgery according to their quantitative ECoG findings was analyzed. Frequency of EDs and HFO ripple rates in preresection ECoG were significantly higher in children with MCD compared with non-MCD (p = 0.018 and p = 0.002, respectively). Higher frequencies of EDs and ripple rates in preresection ECoG were observed in residual seizures than in seizure-free children (p = 0.045 and p = 0.005, respectively). Clinically, children with residual seizures after surgery were significantly younger at the onset, had a trend of higher seizure frequency and higher spike frequency of presurgical videoEEG. Our results suggested that quantification of intraoperative ECoG predicted seizure outcomes and reflected different ED pattern and frequencies between MCD and non-dysplastic histopathology among children who underwent resective epileptic surgery. The results of our study were encouraging and indicated that intraoperative ECoG improved the outcomes of surgery in children with epilepsy.